Hypopituitarism and atherosclerosis

References

• Rosen T, Bengtsson B -A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285–8
   PubMed Web of Science ®Google Scholar
• Bulow B, Hagmar L, Mikoczy Z, Nordstroem C H, Erhrths E M. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75–81
   PubMed Web of Science ®Google Scholar
• Bates A S, van't Hoff, Jones P J, Clayton R N. The effect of hypopituitarism on life expectancy. J. Clin Endocrinol Metub 1996; 81: 1169–72
   PubMed Web of Science ®Google Scholar
• Bates A S, Bullivant B, Sheppard M C, Stewart P M. Life expectancy following surgery for pituitary turnours. Clin Endocrinol 1999; 50: 315–9
   PubMed Web of Science ®Google Scholar
• Tomlinson J W, Holden N, Hills R, Wheatley K, Clayton R N, Bates A S, et al. Premature mortality in 1014 patients with hypopituitarism. Lancet 2001; 357: 425–31
   PubMed Web of Science ®Google Scholar
• Abdu T AM, Neary R, Elhadd T A, Akber M, Clayton R N. Coronary risk in growth hormone deficient adults: increased predicted risk largely due to lipid profile abnormalities. Clinic Endocrinol 2001; 53: 1–9
   Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a prespective for the 1990s. Nature 1993; 362: 801–9
   PubMed Web of Science ®Google Scholar
• Elhadd T A, Kennedy G, Hill A, McLaren M, Newton R W, Greene S A, et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type-I diabetes mellitus in the absence of clinical vascular disease. Diabetes Metab Res Rev 1999; 15: 405–11
   PubMed Web of Science ®Google Scholar
• Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine Rev 2001; 22: 36–52
   PubMed Web of Science ®Google Scholar
• Salomaa V, Matei C, Aleksic N, Sansores-Garcia L, Folsom A R, Juneja H, et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the atherosclerosis risk in Communities (ARK) Study: a case cohort study. Lancet 1999; 353: 1729–34
   PubMed Web of Science ®Google Scholar
• Bridges A B, Hill A, Belch J JF. Cigarette smoking increases white blood cell aggregation in whole blood. J. Roy Soc Med 1993; 86: 139–40
   PubMedGoogle Scholar
• Abe Y, El-Masri B, Kimball K T, Pownall H, Reilley C F, Osmundsen K, et al. Soluble cell adhesion molecules in hypertriglyceridaemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998; 18: 723–31
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton R N. Growth hormone treatment (GH) reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 1999; 84: 453–7
   PubMed Web of Science ®Google Scholar
• Elhadd T A, Abdu T AM, Kennedy G, McLaren M, Oxtoby J, Neary R, et al. Relationship between biochemical and biophysical markers of endothelial dysfunction in adults with growth hormone deficiency: The missing link between hypopituitarisin and reduced life expectancy. J Clin Endocrinol Metab 2001, (in press)
   Google Scholar
• Boger R H, Skamira C, Bode-Boger S M, Brabant G, von zur Muhlen A, Frolich J C. Nitric oxide may mediate the haemodynamics effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin lnvest 1996; 98: 2706–13
   PubMed Web of Science ®Google Scholar
• Evans L M, Davies J S, Goodfellow J, Rees J AE, Scanlon M F. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol 1999; 50: 457–64
   PubMed Web of Science ®Google Scholar
• Kvasnicka J, Marek J, Kvaniscka T, Weiss V, Markova M, Stepan J, et al. Increase of adhesion molecules, fibrinogen, plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and its modulation by recombinant human GH replacement. Clin Endocrinol 2000; 52: 543–8
   PubMed Web of Science ®Google Scholar
• Hwang S J, Ballantyne C M, Sharrett A R, Smith L C, Davis C E, Gotto A M, Jr, et al. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease patients: the Athero-scleosis Risk In Community study (ARIC). Circulation 1997; 96: 4219–25
   PubMed Web of Science ®Google Scholar
• Catto A J, Carter A M, Barrett J H, Bamford J, Rice P J, Grant P J. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtypes and mortality. Thromb Haemost 1997; 77: 1104–8
   PubMed Web of Science ®Google Scholar
• McLaren M, Elhadd T A, Greene S A, Belch J JF. Elevated thrombomodulin and vascular endothelial growth factor in juvenile Type-1 diabetic patients. Clin Appl Thromb Haemost 1999; 5: 214
   Google Scholar
• O'Leary D H, Polak J F, Wolfson S K, Jr, Bond M G, Bommer W, Sheth S, et al. Use of ultrasonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991; 22: 1155–63
   PubMed Web of Science ®Google Scholar
• Salonen J T, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerosis progression. Circulation 1993; 87(Suppl II)56–65
   Google Scholar
• Markussis V, Beshyah S A, Fisher C, Sharp P, Nicholaides A N, Johnston D. Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypo-pituitary adults. Lancet 1992; 340: 1188–92
   PubMed Web of Science ®Google Scholar
• Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J. Clin Endocrinol Metabol 1997; 82: 1378–81
   PubMed Web of Science ®Google Scholar
• Johansson J -O, Landin K, Tengborn L, Rosen T, Bengtsson A -B. High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arterioscler Thromb 1994; 14: 434–7
   PubMed Web of Science ®Google Scholar
• Merola B, Cittadini A, Colao A, Longobardi S, Fazro S, Sabatini D, et al. Cardiac structural and functional abnormalities in adults patients with growth hormone deficiency. J Clin Endocrinol Metabol 1993; 77: 1658–61
   PubMed Web of Science ®Google Scholar
• Shahi M, Beshyah S A, Hackett D, Sharp P S, Johnston D G, Foale R A. Myocardial dysfucntion in treated adults with hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992; 67: 92–6
   Google Scholar
• Wuster C, Slenczka E, Ziegler R. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution? (in German). Klinische Wochenschrift 1991; 69: 769–73
   PubMedGoogle Scholar
• Cuneo R C, Salmon F, Watts G F, Hesp R, Sonksen P H. Growth hormone treatment improves serum lipids and lipoprotein in adult patients with growth hormone deficiency. Metabolism 1993; 42: 1519–23
   PubMed Web of Science ®Google Scholar
• Rosen T, Eden S, Larsson G, Wilhelmsen L, Bengtsson B -A. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologicu 1993; 129: 195–200
   PubMedGoogle Scholar
• Beshyah S A, Henderson A, Niththyananthan R, Sharp P, Richmond W, Johnston D G. Metabolic abnormalities in growth hormone deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metub 1994; 1: 173–80
   Google Scholar
• Al-Shoumer K AS, Cox K H, Hughes C L, Richmond W, Johnston D. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metabol 1997; 82: 2653–9
   PubMed Web of Science ®Google Scholar
• de Boer H, Blok G J, Voerman H J, Philips M, Schouten J A. Serum lipids in growth hormone deficient men. Metabolism 1994; 43: 199–203
   PubMed Web of Science ®Google Scholar
• Taylor R. Insulin action. Clin Endocrinol 1991; 34: 159–71
   PubMedGoogle Scholar
• Weaver J U, Monson J P, Noonan K, John W G, Edwards A, Evans K, et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metabol 1995; 80: 153–9
   PubMedGoogle Scholar
• Page R C, Levy J, Turner R C. Obesity associated insulin resistance occurs in hypopituitary men. Diabet Med 1994; 11: 862–5
   Google Scholar
• Beshyah S A, Gelding S V, Andres C, Johnston D G, Gray I P. Beta-cell function in hypopituitary adults before and after growth hormone treatment. Clin Sci 1995; 89: 321–8
   Google Scholar
• Salomon F, Cuneo R C, Umpleby A M, Sonksen P H. Interaction of body fat and muscle mass with substrate concentration and fasting insulin levels in adults with growth hormone deficiency. Clin Sci 1994; 87: 201–6
   Google Scholar
• Binnert A, Deurenberg P, Swart G R, Wilson J HP, Lambert S WJ. Body composition in growth hormone deficient adults. Am J Clin Nutr 1992; 55: 918–23
   Google Scholar
• Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson B -A. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 1993; 38: 63–71
   PubMed Web of Science ®Google Scholar
• Beshyah S A, Freemantle C, Thomas E, Rutherford O M, Page B, Johnston D G. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol 1995; 42: 178–89
   Google Scholar
• Snel Y E, Brummer R J, Doerga M E, Zeliesen P M, Bakker C J, Hendricks M J, et al. Adipose tissue assessed by magnetic resonance imaging in growth hormone deficient adults: the effects of growth hormone replacement and a comparison with control subjects. Am J Clin Nutr 1995; 61: 1290–4
   PubMed Web of Science ®Google Scholar
• Lapidus L, Bengtson C, Larson B, Pennert K, Ryobo E, Sjorstrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of Gotenburg, Sweden. BMJ 1984; 289: 1257–61
   PubMed Web of Science ®Google Scholar
• Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibbin G. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. BMJ 1984; 288: 1401–4
   PubMed Web of Science ®Google Scholar
• Kissebah A H, Vydelingum N, Murray R, Evans D J, Hartz A J, Kalkhoff R K, et al. Relationship of body fat distribution to metabolic complications of obesity. J. Clin Endocrinol Metabol 1982; 54: 254–60
   PubMed Web of Science ®Google Scholar
• Haffner S, Stem M P, Hazuda H P, Rosenthal M, Knapp J A, Melina R M. Role of obesity and fat distribution in non-insulin dependent diabetes mellitus in Mexican-Americans and non-Hispanic whites. Diabetes Care 1986; 9: 153–61
   PubMed Web of Science ®Google Scholar
• Steinberg H O, Chaker H, Learning R, Johnson A, Brechtel G, Baron A D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 11: 2601–10
   Google Scholar
• Chen N G, Holmes M, Reaven G M. Relationship between insulin resistance, soluble adhesion molecules and mono-nuclear cell binding in healthy volunteers. J. Clin Endocrinol Metabol 1999; 84: 3485–9
   PubMed Web of Science ®Google Scholar
• Merimee T J, Felig P, Marliss E, Fineberg S E, Cahill G C. Glucose and lipid haemostasis in the absence of growth hormone. J. Clin Invest 1971; 50: 574–82
   Google Scholar
• Longobardi S, Coucolo A, Merola B, DiRella F, Colao A, Nikolai E, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol 1998; 48: 137–44
   PubMed Web of Science ®Google Scholar
• Serri O, St Jacques P, Sartppour M, Renier G. Alteration of monocyte function in patients with growth hormone deficiency: effect of substitutive GH therapy. J. Clin Endocrinol Metub 1999; 84: 3405–6
   Google Scholar
• Christ E R, Chowienczyk P J, Sonksen P H, Russell-Jones D L. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity. Clin Endocrinol 1999; 51: 21–5
   Google Scholar
• Evans L M, Davies J S, Anderson R A, Ellis G R, Jackson S K, Lewis M J, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000; 142: 254–62
   Google Scholar
• Russells-Jones D L, Watts G F, Weissberger A, Naoumova R, Myers J, Thompson G R, et al. The effects of growth hormone on serum lipids lipoproteins, apoproteins and cholesterol precursors in adults growth hormone deficient patients. Clin Endocrinol 1994; 41: 345–50
   Google Scholar
• Johansson J -O, Landin K, Tengborn L, Johansson G, Tengborn L, Bengtsson A -B. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-I and tissue plasminogen activator in growth hormone deficient adults. Thromb Haemost 1996; 76: 422–8
   PubMed Web of Science ®Google Scholar
• Bar R S, Boes M, Dake B L, Booth B A, Henley S A, Sandra A. Insulin, insulin-like growth factors, and vascular endothelium. Am J Med 1988; 85(Suppl 5a)59–70
   Google Scholar
• Guse A H, Keiss W, Funk B, Kessler U, Berg I, Gerken G. Identification and characterization of insulin-like growth factor receptor on adult rat cardiac myocytes: linkage to inositol. Endocrinology 1992; 130: 145–51
   PubMedGoogle Scholar
• Haylor J, Singh I, El Nahas A M. Nitric oxide inhibitor prevents vasodilatation by insulin-like growth factor I. Kidney Int 1991; 39: 333–5
   PubMed Web of Science ®Google Scholar
• Tsukahara H, Gordiennko D V, Tonsshoff B, Gelato M C, Golgirsky M S. Direct demonstration of insulin-like growth factor-1 induced nitric oxide production by endothelial cells. Kidney Int 1994; 45: 598–604
   PubMed Web of Science ®Google Scholar
• Flyvbjerg A, Jorgensen K D, Marshall S M, Orskov H. Inhibitory effect of octreotide on growth hormone-induced IGF-1 generation and organ growth in hypophysectomized rats. Am Physiol 1991; 260: E568–74
   Google Scholar
• Howlett T A. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol 1997; 46: 263–8
   PubMed Web of Science ®Google Scholar
• Peacey S R, Guo C -U, Robinson A M, Price A, Giles R, Eastell R, et al. Glucocorticoid replacement therapy: are patients overtreated and does it matter. Clin Endocrinol 1997; 46: 255–62
   PubMed Web of Science ®Google Scholar
• Pupo A A, Wajenchenberg B L, Schnaider J. Carbohydrate metabolism in hypercortisolism. Diabetes 1966; 15: 24–9
   Google Scholar
• Howlett T A, Rees L H, Besser M G. Cushing's syndrome. Clin Endocrinol Metab 1985; 14: 911–45
   PubMedGoogle Scholar
• Beshyah S A. Clinical and metabolic studies on hypopituitary and growth hormone replacement therapy in adults. Imperial College, University of London, London 1994, (dissertation)
   Google Scholar
• Monson J P. The assessment of glucocrticoid replacement therapy. Clin Endocrinol 1997; 46: 269–70
   PubMed Web of Science ®Google Scholar
• Lip G YH, Beavers G, Zarifiz J. Hormone replacement therapy and cardiovascular risk: the ‘cardiovascular physicians’ viewpoint. J Int Med 1995; 238: 389–99
   Google Scholar
• Hutchison S J, Sudhir K, Chou T M, Chatterjee K. Sex hormone and vascular reactivity. Heart 1997; 22: 141–50
   Google Scholar
• Bush D E, Jones C E, Bass K M, Walters G K, Bruza J M, Ouyang P. Oestrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998; 104: 5520–8
   Google Scholar
• Tagawa H, Shimokawa H, Tagawa T, Kuriowa-Matsumoto M, Hiroka Y, Ytakeshita A. Short-term eostrogen augments both nitric oxide-mediated and no-nitric oxide mediated endothelium dependent forearm vasodilatation in postmenopausal women. J. Cardiovasc Pharmacol 1997; 30: 481–8
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, et al. Modulation of endothelial-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92: 3431–5
   PubMed Web of Science ®Google Scholar
• Hayashi T, Fukuto J M, Ingarro L JJ, Chauduri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc Natl Acad Sci USA 1992; 89: 11259–63
   PubMed Web of Science ®Google Scholar
• Basteine P A, Vanhaelest L, Bonnyns M, Neve P, Staguet E. Preclinical hypothyroidism: a risk factor for coronary heart disease. Lancet 1971; 203–4
   Google Scholar
• Hak A, Pols H, Visser T, Drexhage, Hofman A, Witteman J. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000; 132: 270–8
   PubMed Web of Science ®Google Scholar
• Anderson R A, Ellis G R, Evans L M, Davies J S, Jackson S K, Lewis M J, et al. Increased free radical release in hypo-pituitary adults with GHD. J. Endocrinol 1998, Suppl 1: P24
   Google Scholar
• Brada M, Burchell L, Ashley S, Traish D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 1999; 45: 693–8
   PubMed Web of Science ®Google Scholar
• Flickinger J C, Nelson P B, Talor F H, Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989; 63: 2404–8
   Google Scholar
• Murros K E, Tooke J E. The effect of radiation on carotid arteries. Arch Neurol 1989; 46: 449–55
   PubMedGoogle Scholar
• Bowen J, Paulsen C A. Stroke after pituitary irradiation. Stroke 1992; 26: 908–11
   Google Scholar
• Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995; 26: 131–6
   PubMed Web of Science ®Google Scholar
• Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999; 23: 936–42
   Google Scholar
• Caroll P V, Christ E R, Bengtsson B A, Calsson L, Christiansen J S, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin Endocrinol Metubol 1998; 83: 382–395
   Google Scholar
• Beshyah S A, Johnston D. Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol 1999; 50: 1–15
   PubMed Web of Science ®Google Scholar